These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 8916751)
1. Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome. Walker MC; Li LM; Sander JW BMJ; 1996 Nov; 313(7066):1184-5. PubMed ID: 8916751 [No Abstract] [Full Text] [Related]
3. A survey comparing lamotrigine and vigabatrin in everyday clinical practice. Schapel G; Chadwick D Seizure; 1996 Dec; 5(4):267-70. PubMed ID: 8952011 [TBL] [Abstract][Full Text] [Related]
4. Combination vigabatrin and lamotrigine therapy for intractable epilepsy. Schapel GJ; Black AB; Lam EL; Robinson M; Dollman WB Seizure; 1996 Mar; 5(1):51-6. PubMed ID: 8777553 [TBL] [Abstract][Full Text] [Related]
5. New antiepileptic drugs already registered. Wolf P Epilepsia; 1994; 35 Suppl 5():S22-4. PubMed ID: 8039465 [TBL] [Abstract][Full Text] [Related]
6. The new antiepileptic drugs. Appleton RE Arch Dis Child; 1996 Sep; 75(3):256-62. PubMed ID: 8976672 [No Abstract] [Full Text] [Related]
7. Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes. Bélanger S; Coulombe G; Carmant L Epilepsia; 1998 Aug; 39(8):878-83. PubMed ID: 9701380 [TBL] [Abstract][Full Text] [Related]
8. New antiepileptic drugs for children: felbamate, gabapentin, lamotrigine, and vigabatrin. Devinsky O; Vazquez B; Luciano D J Child Neurol; 1994 Oct; 9 Suppl 1():S33-45. PubMed ID: 7822751 [TBL] [Abstract][Full Text] [Related]
9. [Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic]. Vogt H; Krämer G Schweiz Med Wochenschr; 1995 Jan; 125(4):125-32. PubMed ID: 7878401 [TBL] [Abstract][Full Text] [Related]
10. Adjunctive therapy in epilepsy: a cost-effectiveness comparison of alternative treatment options. O'Neill BA; Trimble MR; Bloom DS Seizure; 1995 Mar; 4(1):37-44. PubMed ID: 7788105 [TBL] [Abstract][Full Text] [Related]
11. A survey of lamotrigine and vigabatrin treatment in children with severe epilepsy. Schapel GJ; Wallace SJ; Gordon GS Seizure; 1997 Dec; 6(6):479-83. PubMed ID: 9530945 [TBL] [Abstract][Full Text] [Related]
12. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood. McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564 [TBL] [Abstract][Full Text] [Related]
13. Overview of lamotrigine and the new antiepileptic drugs: the challenge. Pellock JM J Child Neurol; 1997 Nov; 12 Suppl 1():S48-52. PubMed ID: 9429131 [TBL] [Abstract][Full Text] [Related]
14. Acute pancreatitis associated with dual vigabatrin and lamotrigine therapy. Jadresic D Seizure; 1994 Dec; 3(4):319. PubMed ID: 7534594 [No Abstract] [Full Text] [Related]
15. [In children with refractory epilepsy: vigabatrin or lamotrigine?]. Caviedes BE; Herranz JL; Arteaga R; Armijo JA Rev Neurol; 1999 Mar 1-15; 28(5):444-8. PubMed ID: 10229954 [TBL] [Abstract][Full Text] [Related]
16. Newer antiepileptic drugs. Towards an improved risk-benefit ratio. Patsalos PN; Sander JW Drug Saf; 1994 Jul; 11(1):37-67. PubMed ID: 7917080 [TBL] [Abstract][Full Text] [Related]
17. New antiepileptic drugs: a systematic review of their efficacy and tolerability. Marson AG; Kadir ZA; Chadwick DW BMJ; 1996 Nov; 313(7066):1169-74. PubMed ID: 8916746 [TBL] [Abstract][Full Text] [Related]